All treatments
Treatment
Placebo will be identical in appearance to the investigational medicinal product. clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic confirmatory (Phase III)
A prospective, randomized, double-blind placebo-controlled multicentre trial with mannan-conjugated birch pollen allergoids administered subcutaneously to adolescents and adults with birch pollen-induced allergic rhinitis or rhinoconjunctivitis.
This study is looking into a new treatment for birch pollen allergy. It compares a new vaccine-like medicine given by injection to a dummy treatment. The aim is to see if the new medicine can help reduce symptoms like sneezing and itchy eyes during pollen season.
For: birch pollen-induced allergic rhinitis birch pollen-induced allergic rhinoconjunctivitisGermany - Ongoing, recruitingTherapeutic confirmatory (Phase III)
A prospective, randomized, double-blind placebo-controlled multicentre study with mannan-conjugated birch pollen allergoids administered subcutaneously to adolescent and adult patients with birch pollen-induced allergic rhinitis or rhinoconjunctivitis.
This study is looking for people aged 18 and over with birch pollen allergies. It compares a new treatment with a dummy treatment (placebo) to see if it reduces allergy symptoms like a runny nose or itchy eyes during birch pollen season.
For: Birch pollen induced allergic rhinitis or rhinoconjunctivitisGermany · Poland